Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administation of anti-interleukin-2 receptor monoclonal antibody (B-B10). - Herve,P.; Wijdenes,J.; Bergerat,J.P.; Bordigoni,P.; Milpied,N.; Cahn,J.Y.; Clement,C.; Beliard,R.; Morel-Fourrier,B.; Racadot,E.; Troussard,X.; Benz-Lemonie,E.; et al. (Blood, 1990)